UBC-led projects awarded over $5.5 million for clinical trials projects to support the development of new drugs and treatments

On January 19, 2023 the Honourable Filomena Tassi, Minister of the Federal Economic Development Agency for Southern Ontario, on behalf of the Honourable Jean-Yves Duclos, Minister of Health, announced a new investment to support one clinical trials consortium, seven training platforms, and 22 research projects. This is Canada’s largest-ever investment in clinical trials.

Approximately $60M is being awarded to 22 projects to fund clinical trial phases, designs, and objectives that align with the priorities of the Biomanufacturing and Life Sciences Strategy, including two UBC-led projects for a total of over $5.5 million.

Funded UBC-LED Projects

  • A Phase I trial of single domain antibody-based CD22 chimeric antigen receptor (CAR)-T cells for the treatment of relapsed/refractory CD22+ B-cell acute lymphoblastic leukemia
    Principal Investigator: Kevin A. Hay (Medicine)
    Funding Stream: Clinical Trial Projects
  • Randomized Embedded Multifactorial Adaptive Platform Trial of Community Acquired Pneumonia
    Principal Investigator: Srinivas Murthy (Pediatrics)
    Funding Stream: Clinical Trial Projects

View the full announcement

View all funded projects